Complications; Cesarean Section Completed Phase 4 Trials for Bupivacaine (DB00297)

Back to Complications; Cesarean Section

Also known as: Complications, Cesarean Section / Cesarean Section; Complications / Cesarean Section Complications

IndicationStatusPhase
DBCOND0036878 (Complications; Cesarean Section)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04897841Obstetric Liposomal Bupivacaine Via Surgical Transversus Abdominis Plane Block for Post Cesarean Pain ControlTreatment
NCT05502146Comparison of Two Different Norepinephrine Bolus Doses for Management of Spinal Anesthesia-Induced Maternal HypotensionTreatment
NCT04403724Sequential and Mixture Injection of Opioids and Hyperbaric BupivacaineTreatment
NCT03792906Comparison of Two Norepinephrine Bolus Doses for Management of Post-spinal Hypotension During Cesarean DeliveryTreatment
NCT03328533Norepinephrine Versus Phenylephrine Continuous Variable Infusion in Cesarean DeliveryPrevention
NCT03302039Three Protocols for Phenylephrine Administration in Cesarean DeliveryPrevention
NCT03234816Vasopressor Prophylaxis After Spinal AnesthesiaPrevention
NCT03182088Norepinephrine Infusion Different Doses in Cesarean DeliveryPrevention